Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

PBH stock hub

Prestige Consumer Healthcare Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PBHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

PBH

In the news

Latest news · PBH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.2

P25 12.3P50 18.4P75 33.1

Trailing P/E13.9

P25 14.9P50 23.2P75 38.5

ROE10.3

P25 -105.6P50 -46.5P75 -3.1

ROIC8.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PBH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

264

Groups with data

Currency

USD

Showing 264 of 264 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001295947
Company name	Prestige Consumer Healthcare Inc.
Country	United States
Country code	US
Cusip	74112D101
Employees	600
Employees Change	30%
Employees Change Percent	5.26
Enterprise value	$3.5B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2005-02-10
Isin	US74112D1019
Last refreshed	2026-05-10
Market cap	$2.5B
Market cap category	Mid-Cap
Price	$52.54
Price currency	USD
Rev Per Employee	1,839,343.33x
Sector	Healthcare
Sic	2834
Symbol	PBH
Website	https://www.prestigebrands.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.5%
EV Earnings	18.78x
EV Sales Forward	3.04x
EV/EBIT	10.46x
EV/EBITDA	9.6x
EV/FCF	13.11x
EV/Sales	3.17x
FCF yield	10.75%
Forward P/E	11.17x
P/B ratio	1.36x
P/E ratio	13.86x
P/S ratio	2.25x
PE Ratio10 Y	18.34x
PE Ratio3 Y	17.36x
PE Ratio5 Y	15.79x
PEG ratio	1.6x
PS Forward	2.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.34%
EBITDA Margin	33.07%
FCF margin	24.21%
Gross margin	56.99%
Gross Profit	$628.9M
Gross Profit Growth	0.6%
Gross Profit Growth Q	-1.93%
Gross Profit Growth3 Y	0.05%
Gross Profit Growth5 Y	2.35%
Net Income	$186.5M
Net Income Growth	-12.82%
Net Income Growth Q	-23.49%
Net Income Growth Years	2%
Net Income Growth3 Y	-3.93%
Net Income Growth5 Y	2.33%
Pretax Margin	24.16%
Profit Margin	16.9%
Profit Per Employee	$310,835
Profitable Years	2
ROA	6.13
Roa5y	6.08
ROCE	9.98
ROE	10.31
Roe5y	9.47
ROIC	8.37
Roic5y	9.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.76%
Cagr15y	11.08%
Cagr1y	-35.48%
Cagr20y	7.7%
Cagr3y	-4.73%
Cagr5y	2.65%
EPS Growth	-11
EPS Growth Q	-20.49
EPS Growth Years	2
EPS Growth3 Y	-3.04
EPS Growth5 Y	2.94
FCF Growth	7.44%
FCF Growth Q	18.47%
FCF Growth3 Y	5.82%
FCF Growth5 Y	4.96%
OCF Growth	7.82%
OCF Growth Q	20.27%
OCF Growth10 Y	3.91%
OCF Growth3 Y	5.76%
OCF Growth5 Y	3.52%
Revenue Growth	-1.31x
Revenue Growth Q	-2.37x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.16x
Revenue Growth5 Y	2.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.32
Assets	$3.5B
Cash	$62.4M
Current Assets	$433.4M
Current Liabilities	$139.6M
Debt	$1.1B
Debt EBITDA	$2.73
Debt Equity	$0.59
Debt FCF	$4.04
Equity	$1.8B
Interest Coverage	8.03
Liabilities	$1.7B
Long Term Assets	$3.1B
Long Term Liabilities	$1.5B
Net Cash	$-1B
Net Cash By Market Cap	$-40.9
Net Debt EBITDA	$2.79
Net Debt Equity	$0.56
Net Debt FCF	$3.81
Tangible Book Value	$-1.1B
Tangible Book Value Per Share	$-22.26
WACC	5.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.11
Inventory Turnover	3.01
Net Working Capital	$240.1M
Quick ratio	1.81
Working Capital	$293.9M
Working Capital Turnover	$3.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.66%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-7.35%
1Y total return	-35.46%
200-day SMA	63.08
3Y total return	-13.53%
50-day SMA	59.64
50-day SMA vs 200-day SMA	50under200
5Y total return	13.97%
All Time High	90.04
All Time High Change	-41.65%
All Time High Date	2025-03-10
All Time Low	3.92
All Time Low Change	1,240.31%
All Time Low Date	2009-03-12
ATR	2.1
Beta	0.4
Beta1y	0.37
Beta2y	0.35
Ch YTD	-14.83
High	54.77
High52	89.37
High52 Date	2025-05-16
High52ch	-41.21%
Low	51.79
Low52	51.24
Low52 Date	2026-04-06
Low52ch	2.54%
Ma50ch	-11.91%
Price vs 200-day SMA	-16.71%
RSI	32.11
RSI Monthly	37.48
RSI Weekly	29.57
Sharpe ratio	-1.6x
Sortino ratio	-1.8
Total Return	1.66%
Tr YTD	-14.83
Tr15y	383.35%
Tr1m	-5.54%
Tr1w	-4.63%
Tr3m	-20.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$65
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$1.4
Earnings EPS Estimate Growth	6.06
Earnings Revenue Estimate	293,816,800x
Earnings Revenue Estimate Growth	6.07x
Operating Income	$334.8M
Operating Income Growth	1.3
Operating Income Growth Q	-10.3
Operating Income Growth3 Y	-0.72
Operating Income Growth5 Y	2.19
Operating margin	30.34
Price target	$73
Price Target Change	$38.94
Price Target Change Top	$23.72

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,642,136%
Float Percent	98.57%
Net Borrowing	35,592,000
Shares Insiders	1.4%
Shares Institutions	110.5%
Shares Out	47,318,730
Shares Qo Q	-2.39%
Shares Yo Y	-1.66%
Short Float	4.93%
Short Ratio	4.07
Short Shares	4.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$256.3M
Average Volume	490,060.8x
Bv Per Share	38.66
CAPEX	$-9.4M
Ch10y	-7.35
Ch15y	383.3
Ch1m	-5.54
Ch1w	-4.63
Ch1y	-35.46
Ch20y	341.1
Ch3m	-20.79
Ch3y	-13.53
Ch5y	13.97
Ch6m	-12.36
Change	-3.76%
Change From Open	-2.92
Close	54.59
Days Gap	-0.86
Depreciation Amortization	30,173,000
Dollar Volume	38,964,136.9
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$334.8M
EBITDA	$365M
EPS	$3.79
F Score	5
FCF	$267.2M
FCF EV Yield	7.63x
FCF Per Share	$5.65
Financing CF	-129,451,000
Fiscal Year End	March
Founded	1,996
Goodwill	581,248,000
Graham Number	57.42818
Graham Upside	9.3
Income Tax	$80.2M
Investing CF	-136,906,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2025-05-09
Lynch Fair Value	$18.96
Lynch Upside	-63.92
Ma150	61.81
Ma150ch	-15%
Ma20	56.67
Ma20ch	-7.28%
Net CF	11,499,000
Next Earnings Date	2026-05-13
Open	54.12
Optionable	Yes
P FCF Ratio	9.3
P OCF Ratio	8.99
Position In Range	25.17
Post Close	52.54
Postmarket Change Percent	-0.04
Postmarket Price	$52.52
Ppne	174,738,000
Price Date	2026-05-08
Price EBITDA	$6.81
Relative Volume	1.51x
Revenue	1,103,606,000x
SBC By Revenue	0.99x
Share Based Comp	10,921,000
Tax By Revenue	7.27x
Tax Rate	30.07%
Tr20y	341.14%
Tr6m	-12.36%
Us State	New York
Volume	741,609
Z Score	2.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PBH pay a dividend?

Capital-return profile for this ticker.

Performance

PBH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PBH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+110.5%

Float: +98.6% of shares outstanding

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PBH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.1

Neutral momentum band

Price vs 200-day MA

-16.7%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-1.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PBH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PBH stock rating?

Prestige Consumer Healthcare Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PBH analysis?

The full report lives at /stocks/PBH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PBH?

The latest report frames PBH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PBH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.